Furthermore, an assay designed to evaluate the POU4F3 gene methylation in liquid-based cytology samples of HPV-positive women appeared to be a noteworthy method for cervical cancer detection and is under clinical trial evaluation [109]. This evidence concerns the gene POU4F3 and cervical carcinoma.